T-cell lymphomas in South america and europe

Monica Bellei, Carlos Sergio Chiattone, Stefano Luminari, Emanuela Anna Pesce, Maria Elena Cabrera, Carmino Antonio de Souza, Raul Gabús, Lucia Zoppegno, Lucia Zoppegno, Jorge Milone, Astrid Pavlovsky, Joseph Michael Connors, Francine Mary Foss, Steven Michael Horwitz, Raymond Liang, Silvia Montoto, Stefano Aldo Pileri, Aaron Polliack, Julie Marie Vose, Pier Luigi Zinzani, Emanuele Zucca, Massimo Federico, Monica Bellei, Carlos Sergio Chiattone, Stefano Luminari, Emanuela Anna Pesce, Maria Elena Cabrera, Carmino Antonio de Souza, Raul Gabús, Lucia Zoppegno, Lucia Zoppegno, Jorge Milone, Astrid Pavlovsky, Joseph Michael Connors, Francine Mary Foss, Steven Michael Horwitz, Raymond Liang, Silvia Montoto, Stefano Aldo Pileri, Aaron Polliack, Julie Marie Vose, Pier Luigi Zinzani, Emanuele Zucca, Massimo Federico

Abstract

Peripheral T-cell lymphomas are a group of rare neoplasms originating from clonal proliferation of mature post-thymic lymphocytes with different entities having specific biological characteristics and clinical features. As natural killer cells are closely related to T-cells, natural killer-cell lymphomas are also part of the group. The current World Health Organization classification recognizes four categories of T/natural killer-cell lymphomas with respect to their presentation: disseminated (leukemic), nodal, extranodal and cutaneous. Geographic variations in the distribution of these diseases are well documented: nodal subtypes are more frequent in Europe and North America, while extranodal forms, including natural killer-cell lymphomas, occur almost exclusively in Asia and South America. On the whole, T-cell lymphomas are more common in Asia than in western countries, usually affect adults, with a higher tendency in men, and, excluding a few subtypes, usually have an aggressive course and poor prognosis. Apart from anaplastic lymphoma kinase-positive anaplastic large cell lymphoma, that have a good outcome, other nodal and extranodal forms have a 5-year overall survival of about 30%. According to the principal prognostic indexes, the majority of patients are allocated to the unfavorable subset. In the past, the rarity of these diseases prevented progress in the understanding of their biology and improvements in the efficaciousness of therapy. Recently, international projects devoted to these diseases created networks promoting investigations on T-cell lymphomas. These projects are the basis of forthcoming cooperative, large scale trials to detail biologic characteristics of each sub-entity and to possibly individuate targets for new therapies.

Keywords: Europe; Hematologic neoplasms; Killer-cells, natural; Lymphoma, T- cell/ pathology; Lymphoma, T-Cell/classification; Lymphoma, T-cell/epidemiology; Prognosis; South America.

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interest

References

    1. Rappaport H.Tumors of the hematopoietic system. Washington DC: Armed Forces Institute of Pathology (US); 1966. 442 p.
    1. Lennert K, Mohiri N.Malignant lymphoma, lymphocytic T-zone type (T-zone lymphoma) In: Lennert K.Malignant lymphomas other than Hodgkin's disease. Berlin: Springer Verlag; 1978. p. 196-209
    1. Knowles DM.Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. Am J Pathol. 1989; 134(4): 761-85
    1. Pinkus GS, Said JW, Hargreaves H.Malignant lymphoma, T-cell type. A distinct morphologic variant with large multilobated nuclei, with a report of four cases. Am J Clin Pathol. 1979; 72(4): 540-50
    1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994; 84(5): 1361-92 Comment in: Blood. 1994;84(5):1359-60, Blood. 1995;85(3):857-60. Blood. 1996;88(6):2361-2. Blood. 1995;85(7):1972-4. Blood. 1996;87(1):412-3
    1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999; 17(12): 3835-49 Comment in: J Clin Oncol. 2000;18(14):2788-9. J Clin Oncol. 2000;18(19):3447-52
    1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al.WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008.
    1. Rüdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA, Nathwani BN, Ullrich F, Müller-Hermelink HK, Non-Hodgkin's Lymphoma Classification Project Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 2002; 13(1): 140-9
    1. Liang R.State of art on T-cell lymphomas: the epidemiology. Haematologica Reports. 2006; 2(13): 1-3
    1. Vose JM.Peripheral T-cell non-Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2008; 22(5): 997-1005
    1. Ascani S, Zinzani PL, Gherlinzoni F, Sabattini E, Briskomatis A, de Vivo A, et al. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Ann Oncol. 1997; 8(6): 583-92
    1. Anderson JR, Armitage JO, Weisenburger DD.Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998; 9(7): 717-20
    1. Melnyk A, Rodriguez A, Pugh WC, Cabannillas F.Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood. 1997; 89(12): 4514-20
    1. Luminari S, Federico M.Other peripheral T-cell lymphomas In: Magrath IT.The lymphoid neoplasms. 3th ed London: Edward Arnold; 2010. p.1400-20
    1. Howlader N, Ries LA, Mariotto AB, Reichman ME, Ruhl J, Cronin KA.Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst. 2010; 102(20): 1584-98
    1. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F, HAEMACARE Working Group Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010; 116(19): 3724-34 Erratum in: Blood. 2011;117(12):3477
    1. Marcos-Gragera R, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Maynadie M, Luminari S, Ferretti S, Johannesen TB, Sankila R, Karjalainen-Lindsberg ML, Simonetti A, Martos MC, Raphaël M, Giraldo P, Sant M, HAEMACARE Working Group Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project. Haematologica. 2011; 96(5): 720-8
    1. Nakamura S, Koshikawa T, Koike K, Kitoh K, Suzuki H, Oyama A, et al. Phenotypic analysis of peripheral T cell lymphoma among the Japanese. Acta Pathol Jpn. 1993; 43(7-8): 396-412
    1. Armitage JO, Weisenburger DD.New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998; 16(8): 2780-95
    1. Tse E, Kwong YL.Treatment algorithms for mature T-cell and natural killer-cell neoplasms. Future Oncol. 2011; 7(9): 1101-12
    1. Gualco G, Domeny-Duarte P, Chioato L, Barber G, Natkunam Y, Bacchi CE.Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis. Am J Surg Pathol. 2011; 35(8): 1195-203
    1. Pombo De Oliveira MS, Loureiro P, Bittencourt A, Chiattone C, Borducchi D, De Carvalho SM, et al. Geographic diversity of adult t-cell leukemia/lymphoma in Brazil. The Brazilian ATLL Study Group. Int J Cancer. 1999; 83(3): 291-8
    1. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS.Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood. 2006; 107(1): 265-76
    1. Su IJ, Wang CH, Cheng AL, Chen YC, Hsieh HC, Chen CJ, et al. Characterization of the spectrum of postthymic T-cell malignancies in Taiwan. A clinicopathologic study of HTLV-1positive and HTLV-1-negative cases. Cancer. 1988; 61(10): 2060-70
    1. Pombo-de-Oliveira MS, Carvalho SM, Borducchi D, Dobbin J, Salvador J, Correa RB, et al. Adult T-cell leukemia/lymphoma and cluster of HTLV-I associated diseases in Brazilian settings. Leuk Lymphoma. 2001; 42(1-2): 135-44
    1. Pombo de Oliveira MS, Matutes E, Schulz T, Carvalho SM, Noronha H, Reaves JD, et al. T-cell malignancies in Brazil. Clinicopathological and molecular studies of HTLV-I-positive and negative cases. Int J Cancer. 1995; 60(6): 823-7
    1. López-Guillermo A, Cid J, Salar A, López A, Montalbán C, Castrillo JM, et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol. 1998; 9(8): 849-55
    1. Vose J, Armitage J, Weisenburger D, International T-Cell Lymphoma Project International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008; 26(25): 4124-30
    1. Arrowsmith ER, Macon WR, Kinney MC, Stein RS, Goodman SA, Morgan DS, et al. Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification. Leuk Lymphoma. 2003; 44(2): 241-9
    1. Gascoyne RD, Aoun P, Wu D, Chhanabhai M, Skinnider BF, Greiner TC, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood. 1999; 93(11): 3913-21
    1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The NonHodgkin's Lymphoma Classification Project. Blood. 1997; 89(11): 3909-18
    1. Federico M, Bellei M, Pesce E, Zucca E, Pileri S, Montoto S, et al. T-Cell Project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma. Rev Bras Hematol Hemoter. 2009; 31(Suppl2): 21-5
    1. Prospective collection of data in patients with Peripheral T-Cell Lymphoma (T-Cell Project) [Internet] Itália: Associazione Angela Serra per la ricerca sul cancro; 2010. [cited 2011 Nov 20] Available from:
    1. Federico M, Bellei M, Pesce EA, Zucca E, Pileri S, Montoto S, et al. T-Cell Project: an international, prospective, observational study of patients with aggressive peripheral T-cell lymphoma. Analysis of the first 524 patients. Poster session presented at: 11th International Conference on Malignant Lymphoma; 2011 June 15-18. Lugano, Switzerland. Ann Oncol. 22(Suppl4): 241

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する